Unraveling the complexity of amyloid polymorphism using gold nanoparticles and cryo-EM

Authors:

Abstract
Significance: The ability of proteins to self-assemble into different types of fibrils with distinct morphologies has been linked to the pathological and clinical heterogeneity of amyloid diseases such as Alzheimer’s disease and Parkinson’s disease. Here, we describe nanoparticles (NPs) that efficiently label amyloid fibrils produced in vitro or isolated from postmortem tissues, under hydrating conditions and in such a way as to unmask their polymorphism and morphological features. Using these NPs, we show that pathological aggregates exhibit exceptional morphological homogeneity compared with amyloid fibrils produced in vitro, consistent with the emerging view that the physiologic milieu is a key determinant of amyloid fibril strains. These advances pave the way for elucidating the structural basis of amyloid strains and toxicity.
All Related Versions
Funding Information
  • EC | Horizon 2020 (642196)
  • Deutsche Forschungsgemeinschaft (FA 456/27)

This publication has 60 references indexed in Scilit: